Alexander Backes

Title: Innovations of Alexander Backes in Pharmaceutical Chemistry

Introduction

Alexander Backes, a notable inventor based in Munich, Germany, has made significant contributions to the field of pharmaceutical chemistry. With his focus on the development of novel therapeutic agents, he has emerged as a distinguished figure in the realm of medicinal research.

Latest Patents

Backes holds a patent for "Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases." This innovative invention describes the application of 4,6-disubstituted aminopyrimidine derivatives and their pharmaceutically acceptable salts as active agents in the treatment of various diseases, including infections, autoimmune disorders, cardiovascular diseases, and neurodegenerative conditions. Furthermore, the patent details their use as inhibitors for protein kinases and their potential in enriching nucleotide-binding proteins in immobilized forms, enhancing therapeutic applications.

Career Highlights

Throughout his career, Backes has made significant strides in pharmaceutical discovery working with esteemed organizations. He has contributed to research and development at Lead Discovery Center GmbH and Bayer Pharma Aktiengesellschaft, where his expertise in medicinal chemistry has influenced the advancement of new therapeutic solutions.

Collaborations

While working in these reputable institutions, Backes collaborated with talented professionals such as Axel Choidas and Matt Cotten. Their collective efforts have fostered a dynamic environment for research and innovation, leading to the development of impactful pharmaceutical agents.

Conclusion

Alexander Backes stands out as a pioneering inventor whose work on aminopyrimidine derivatives illustrates the vital role of innovation in the pharmaceutical industry. His contributions not only hold promise for the treatment of various diseases but also exemplify the collaborative spirit that drives advancements in medical science.